Myocardial steatosis across the spectrum of human health and disease.
Oneglia AP, Szczepaniak LS, Zaha VG, Nelson MD.
Exp Physiol. 2024 Feb;109(2):202-213. doi: 10.1113/EP091566. Epub 2023 Dec 8.
Cocaine use may modify HIV/ART-associated myocardial steatosis and hepatic steatosis.
Lai S, Gerstenblith G, Moore RD, Celentano DD, Bluemke DA, Treisman G, Liu CY, Li J, Chen S, Kickler T, Lai H.
Drug Alcohol Depend. 2017 Aug 1;177:84-92. doi: 10.1016/j.drugalcdep.2017.03.029. Epub 2017 May 26.
Effect of empagliflozin on ectopic fat stores and myocardial energetics in type 2 diabetes: the EMPACEF study.
Gaborit B, Ancel P, Abdullah AE, Maurice F, Abdesselam I, Calen A, Soghomonian A, Houssays M, Varlet I, Eisinger M, Lasbleiz A, Peiretti F, Bornet CE, Lefur Y, Pini L, Rapacchi S, Bernard M, Resseguier N, Darmon P, Kober F, Dutour A.
Cardiovasc Diabetol. 2021 Mar 1;20(1):57. doi: 10.1186/s12933-021-01237-2.
Myocardial steatosis and left ventricular contractile dysfunction in patients with severe aortic stenosis.
Mahmod M, Bull S, Suttie JJ, Pal N, Holloway C, Dass S, Myerson SG, Schneider JE, De Silva R, Petrou M, Sayeed R, Westaby S, Clelland C, Francis JM, Ashrafian H, Karamitsos TD, Neubauer S.
Circ Cardiovasc Imaging. 2013 Sep;6(5):808-16. doi: 10.1161/CIRCIMAGING.113.000559. Epub 2013 Jul 5.
Myocardial steatosis as a possible mechanistic link between diastolic dysfunction and coronary microvascular dysfunction in women.
Wei J, Nelson MD, Szczepaniak EW, Smith L, Mehta PK, Thomson LE, Berman DS, Li D, Bairey Merz CN, Szczepaniak LS.
Am J Physiol Heart Circ Physiol. 2016 Jan 1;310(1):H14-9. doi: 10.1152/ajpheart.00612.2015. Epub 2015 Oct 30.
Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease.
Lee HH, Lee HA, Kim EJ, Kim HY, Kim HC, Ahn SH, Lee H, Kim SU.
Gut. 2024 Feb 23;73(3):533-540. doi: 10.1136/gutjnl-2023-331003.
Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
Vrentzos E, Ikonomidis I, Pavlidis G, Katogiannis K, Korakas E, Kountouri A, Pliouta L, Michalopoulou E, Pelekanou E, Boumpas D, Lambadiari V.
Cardiovasc Diabetol. 2024 Jul 10;23(1):245. doi: 10.1186/s12933-024-02326-8.
Hepatic steatosis and advanced hepatic fibrosis are independent predictors of long-term mortality in acute myocardial infarction.
Chin Y, Lim J, Kong G, Ng CH, Goh R, Muthiah M, Mehta A, Chong B, Lin C, Chan KE, Kong W, Poh KK, Foo R, Chai P, Yeo TC, Low AF, Lee CH, Tan HC, Chan MY, Richards AM, Loh PH, Chew NWS.
Diabetes Obes Metab. 2023 Apr;25(4):1032-1044. doi: 10.1111/dom.14950. Epub 2023 Jan 6.
Myocardial steatosis and its association with obesity and regional ventricular dysfunction: evaluated by magnetic resonance tagging and 1H spectroscopy in healthy African Americans.
Liu CY, Bluemke DA, Gerstenblith G, Zimmerman SL, Li J, Zhu H, Lai S, Lai H.
Int J Cardiol. 2014 Mar 15;172(2):381-387. doi: 10.1016/j.ijcard.2014.01.074. Epub 2014 Jan 24.
Dual roles of myocardial mitochondrial AKT on diabetic cardiomyopathy and whole body metabolism.
Chen YH, Ta AP, Chen Y, Lee HC, Fan W, Chen PL, Jordan MC, Roos KP, MacGregor GR, Yang Q, Edwards RA, Li J, Wang PH.
Cardiovasc Diabetol. 2023 Oct 27;22(1):294. doi: 10.1186/s12933-023-02020-1.
